Lee, K., et al. (2016) Inhibition of VCAM-1 Expression on Mouse Vascular Smooth Muscle Cells by Lobastin via Downregulation of p38, ERK 1/2 and NF-κB Signaling Pathways. Archives of Pharmacal Research, 39, 83-93.
https://doi.org/10.1007/s12272-015-0687-3

has been cited by the following article:

• TITLE: Expression of Circulating Plasma Long Non-Coding RNA uc063iod.1 and Its Relationship with Coronary Artery Disease

  AUTHORS: Vaidya Rajan, Genshan Ma, Hong Jin

  KEYWORDS: LncRNA uc063iod.1, LncRNA E330013P06, Coronary Artery Disease, Plasma, qRT-PCR

  JOURNAL NAME: Open Journal of Internal Medicine, Vol.8 No.2, April 28, 2018

  ABSTRACT: Objective: To investigate the expression of LncRNA uc063iod.1 in patients with different diseases and to explore the correlation between expression level of LncRNA uc063iod.1 and Coronary Artery Disease (CAD). Method: Plasma samples were prepared using the blood extracted from total 101 patients undergoing coronary artery angiogram (63 CAD patients and 38 non CAD patients). The expression level of LncRNA uc063iod.1 was detected using quantitative real time polymerase chain reaction (qRT-PCR) and the relationship between expression level of LncRNA uc063iod.1 and CAD was explored. The clinicopathological features of patients with CAD were also discussed in our study. Results: The expression of LncRNA uc063iod.1 was significantly increased in the plasma of patients with CAD (p Conclusion: Upregulation of LncRNA uc063iod.1 in plasma can be used as a biomarker for the diagnosis of CAD.